Data as of May 17
| +0.99 / +0.99%|
The 23 analysts offering 12-month price forecasts for Allergan Inc have a median target of 115.00, with a high estimate of 131.00 and a low estimate of 90.00. The median estimate represents a +13.40% increase from the last price of 101.41.
The current consensus among 29 polled investment analysts is to Buy stock in Allergan Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.